Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-004301

Options or other derivatives

  • VP, Chief Accounting Officer acquired 42,631 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Peraza Lisa VP, Chief Accounting Officer 2023-01-18 Grant or award · Performance Stock Units +42,631 42,631 D
Loading xslF345X03/doc4.xml…